Humanized antibodies that recognize β-amyloid peptide
US7700751B2 · kind B2 · utility
31Cited by
175References
86Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 16, 2007 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | Oct 16, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/77
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.